
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Division of Clinical Pharmacology and Experimental Therapeutics, Departments of Medicine, Psychiatry, and Biopharmaceutical Sciences, University of California, San Francisco and 2 Biomarkers Laboratory, Emergency Response and Air Toxicants Branch, Division of Laboratory Science, National Center for Environmental Health, Centers for Disease Control, Atlanta, Georgia
Requests for reprints: Neal L. Benowitz, Chief, Division of Clinical Pharmacology and Experimental Therapeutics, University of California at San Francisco, Box 1220, San Francisco, CA 94143-1220. Phone: 415-206-8324; Fax: 415-206-4956. E-mail: nbeno{at}itsa.ucsf.edu
Objectives: "Light" cigarettes are extremely popular and are perceived by many smokers as less hazardous than higher-yield cigarettes. The objectives of this study were (a) to assess a battery of biomarkers of tobacco smoke exposure that includes tobacco smoke carcinogens, (b) to examine the behavioral nature of compensation, and (c) to examine the consistency of an individual's tobacco smoke exposure when smoking the same cigarette at different times.
Methods: The study was a 3-week crossover study in which smokers smoked their usual cigarettes during weeks 1 and 3, and a light cigarette, with a machine-determined nicotine yield of about 50% of the usual cigarette, during week 2. Blood and urine biomarkers of exposure and subjective questionnaires were collected weekly.
Results: Based on cotinine and carboxyhemoglobin levels, compensation averaged 78% and 83%, respectively. Urinary excretion of 4-(methylnitrosamino)-1-(3-pyridyl)-butanol, a metabolite of the tobacco specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-butanone, and a number of polycyclic aromatic hydrocarbon metabolites was similar in all conditions. Compensation was accomplished both by smoking cigarettes more intensively and by smoking more cigarettes per day. Exposures to various tobacco smoke constituents while smoking the usual brand of cigarette in weeks 1 and 3 were highly correlated.
Conclusion: Our findings support the idea that smokers compensate to a high degree when switched from their usual brand to a light cigarette. Short-term switching resulted in no significant reduction in carcinogen exposure. Our assessment, based on measures of biochemical exposures, supports the idea that switching to light cigarettes is unlikely to reduce the health risks of cigarette smoking.
This article has been cited by other articles:
![]() |
N. L. Benowitz, S. M. Hall, S. Stewart, M. Wilson, D. Dempsey, and P. Jacob III Nicotine and Carcinogen Exposure with Smoking of Progressively Reduced Nicotine Content Cigarette Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2479 - 2485. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J Anderson, P. M Ling, and S. A Glantz Implications of the federal court order banning the terms "light" and "mild": what difference could it make? Tob. Control, August 1, 2007; 16(4): 275 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Stepanov, S. S. Hecht, B. Lindgren, P. Jacob III, M. Wilson, and N. L. Benowitz Relationship of Human Toenail Nicotine, Cotinine, and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol to Levels of These Biomarkers in Plasma and Urine Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1382 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Strasser, R. J. O'Connor, M. E. Mooney, and E. P. Wileyto Digital Image Analysis of Cigarette Filter Stains as an Indicator of Compensatory Smoking Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2565 - 2569. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. O'Connor, G. A. Giovino, L. T. Kozlowski, S. Shiffman, A. Hyland, J. T. Bernert, R. S. Caraballo, and K. M. Cummings Changes in Nicotine Intake and Cigarette Use Over Time in Two Nationally Representative Cross-Sectional Samples of Smokers Am. J. Epidemiol., October 15, 2006; 164(8): 750 - 759. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |